细胞动力

CYTK NASDAQ
11.68
+0.05
+0.43%
交易中 14:14 07/23 EDT
开盘
11.56
昨收
11.63
最高
11.70
最低
11.38
成交量
32.34万
成交均量(3M)
48.38万
52周最高
11.86
52周最低
5.75
换手率
0.56%
市值
6.74亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供细胞动力 CYTK股票价格,细胞动力股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Cytokinetics, Incorporated is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. It is focused on the discovery and development of small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. Its drug candidates, which are in clinical development include tirasemtiv, CK-2127107 and omecamtiv mecarbil. Its tirasemtiv and CK-2127107 are skeletal muscle troponin activators. It is developing tirasemtiv drug candidate for the treatment of Amyotrophic lateral sclerosis (ALS). The Company is developing CK-2127107 for the potential treatment of spinal muscular atrophy, chronic obstructive pulmonary disease and ALS. The Omecamtiv mecarbil is a cardiac muscle myosin activator, which is being evaluated for the treatment of heart failure.
展开 >

最近浏览

名称
价格
涨跌幅